TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DIABETIC ASSAYS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING PREVALENCE OF DIABETES
3.1.2 INCREASING GERIATRIC POPULATION
3.1.3 TECHNOLOGICAL ADVANCEMENT
3.1.4 AVAILABILITY OF REIMBURSEMENT
3.1.5 INCREASING DEMAND FOR THE HAND-HELD DIAGNOSTIC DEVICES
3.2 RESTRAINT
3.2.1 PRODUCT RECALL
3.2.2 HIGH COST OF THE ASSAY
3.2.3 IMPLEMENTATION OF EXCISE DUTY BY THE U.S. GOVERNMENT
3.3 OPPORTUNITIES
3.3.1 RISING GOVERNMENT INITIATIVES
3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS
3.3.3 RISE IN AWARENESS AMONG THE POPULATION
3.3.4 GROWING HEALTHCARE INFRASTRUCTURE
?
3.4 CHALLENGES
3.4.1 STRINGENT REGULATION
3.4.2 LACK OF SKILLED PROFESSIONALS
3.4.3 LOW PENETRATION IN DEVELOPING ECONOMIES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 REGULATORY PROCEDURE
7 NORTH AMERICA DIABETIC ASSAYS MARKET, BY TYPE
7.1 OVERVIEW
7.2 ASSAYS
7.2.1 DIABETES DIAGNOSTICS GLUCOSE ASSAY
7.2.2 DIABETES DIAGNOSTICS HBA1C ASSAY
7.3 DEVICES
7.3.1 ANALYZERS
7.3.2 SOFTWARE
7.4 CONSUMABLES
7.4.1 TEST STRIPS
7.4.2 REAGENT
7.4.3 OTHERS
8 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 TYPE 2 DIABETES
8.3 TYPE 1 DIABETES
8.4 GESTATIONAL DIABETES
9 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT
9.1 OVERVIEW
9.2 AUTOMATED
9.3 MANUAL
10 NORTH AMERICA DIABETIC ASSAYS MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 DIAGNOSTIC LABORATORIES
10.4 CLINICS
10.5 ACADEMIC INSTITUTES
10.6 OTHERS
11 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT
11.3 INDIRECT
12 NORTH AMERICA DIABETIC ASSAYS MARKET, BY GEOGRAPHY
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA DIABETIC ASSAYS MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 COMPANY PROFILE
14.1 BIO-RAD LABORATORIES, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 ABBOTT
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.3 SIEMENS HEALTHINEERS AG
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENT
14.4 DANAHER
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
?
14.5 DIASORIN S.P.A.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT
14.6 ABNOVA CORPORATION
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 ALPCO
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 BIOASSAY SYSTEMS
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.10 DIAZYME LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 DRG INSTRUMENTS GMBH
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 EKF DIAGNOSTICS HOLDINGS PLC
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 ETHOS BIOSCIENCES, INC.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
?
14.14 MEDIPAN GMBH
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 MERCK KGAA
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENT
14.16 MONOBIND INC.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 ORGENTEC DIAGNOSTIKA GMBH
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 ORTHO CLINICAL DIAGNOSTICS
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 PTS DIAGNOSTICS (A SUBSIDIARY OF SANNUO BIOSENSOR CO., LTD.)
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.20 TOSOH CORPORATION
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS